Article | Published:

Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia

Nature Neuroscience volume 12, pages 13001307 (2009) | Download Citation

Abstract

Cardiac arrest victims may experience transient brain hypoperfusion leading to delayed death of hippocampal CA1 neurons and cognitive impairment. We prevented this in adult rats by inhibiting the expression of transient receptor potential melastatin 7 (TRPM7), a transient receptor potential channel that is essential for embryonic development, is necessary for cell survival and trace ion homeostasis in vitro, and whose global deletion in mice is lethal. TRPM7 was suppressed in CA1 neurons by intrahippocampal injections of viral vectors bearing shRNA specific for TRPM7. This had no ill effect on animal survival, neuronal and dendritic morphology, neuronal excitability, or synaptic plasticity, as exemplified by robust long-term potentiation (LTP). However, TRPM7 suppression made neurons resistant to ischemic death after brain ischemia and preserved neuronal morphology and function. Also, it prevented ischemia-induced deficits in LTP and preserved performance in fear-associated and spatial-navigational memory tasks. Thus, regional suppression of TRPM7 is feasible, well tolerated and inhibits delayed neuronal death in vivo.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

GenBank/EMBL/DDBJ

References

  1. 1.

    & Targeting cell death. Clin. Pharmacol. Ther. 82, 370–373 (2007).

  2. 2.

    & Dementia with bilateral medial temporal lobe ischemia. Neurology 35, 1793–1797 (1985).

  3. 3.

    , , & Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37, 1281–1286 (1987).

  4. 4.

    et al. The GluR2 hypothesis: Ca2+-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb. Symp. Quant. Biol. 61, 373–384 (1996).

  5. 5.

    , , & Behavioral performance of rats following transient forebrain ischemia. Stroke 15, 558–562 (1984).

  6. 6.

    Global ischemia and behavioral deficits. Prog. Neurobiol. 58, 279–295 (1999).

  7. 7.

    Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431–1568 (1999).

  8. 8.

    , , , & Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol. Sci. 29, 268–275 (2008).

  9. 9.

    et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 115, 863–877 (2003).

  10. 10.

    , & The TRP channels, a remarkably functional family. Cell 108, 595–598 (2002).

  11. 11.

    et al. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121, 49–60 (2003).

  12. 12.

    et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411, 590–595 (2001).

  13. 13.

    et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114, 191–200 (2003).

  14. 14.

    et al. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science 322, 756–760 (2008).

  15. 15.

    , & Acidosis related brain damage. in Advances in Neurology: Cellular and Molecular Mechanisms of Ischemic Brain Damage (eds. Siesjo, B.K. & Wieloch, T.) (Raven Press, New York, 1994).

  16. 16.

    & Intracellular and exctracellular changes of [Ca2+] in hypoxia and ischemia in rat brain in vivo. J. Gen. Physiol. 95, 837–866 (1990).

  17. 17.

    et al. Microdialysis analyzer and flame atomic absorption spectrometry in the determination of blood glucose, lactate and magnesium in gerbils subjected to cerebral ischemia/reperfusion. J. Am. Coll. Nutr. 23, 556S–560S (2004).

  18. 18.

    , & TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291, 1043–1047 (2001).

  19. 19.

    , & Distinct properties of CRAC and MIC channels in RBL cells. J. Gen. Physiol. 120, 221–235 (2002).

  20. 20.

    et al. TRPM7 channels in hippocampal neurons detect levels of extracellular divalent cations. Proc. Natl. Acad. Sci. USA 104, 16323–16328 (2007).

  21. 21.

    et al. A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J. Pharmacol. Sci. 101, 66–76 (2006).

  22. 22.

    , , , & Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263–264 (2003).

  23. 23.

    , , , & Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839 (2003).

  24. 24.

    et al. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J. Biol. Chem. 280, 37763–37771 (2005).

  25. 25.

    , & Effect of lamotrigine on the Ca2+-sensing cation current in cultured hippocampal neurons. J. Neurophysiol. 86, 2520–2526 (2001).

  26. 26.

    , & Extracellular calcium sensed by a novel cation channel in hippocampal neurons. Proc. Natl. Acad. Sci. USA 94, 7012–7017 (1997).

  27. 27.

    & A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267–272 (1979).

  28. 28.

    , & Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491–498 (1982).

  29. 29.

    et al. Oxidative stress and neuronal death/survival signaling in cerebral ischemia. Mol. Neurobiol. 31, 105–116 (2005).

  30. 30.

    & Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 12, 1035–1040 (1999).

  31. 31.

    et al. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK. J. Neurochem. 77, 1418–1421 (2001).

  32. 32.

    , & Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56, 149–171 (1998).

  33. 33.

    , & Indentification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501 (1992).

  34. 34.

    & Hippocampal involvement in contextual modulation of fear extinction. Hippocampus 17, 749–758 (2007).

  35. 35.

    , , & Learning induces long-term potentiation in the hippocampus. Science 313, 1093–1097 (2006).

  36. 36.

    , & The molecular basis of CaMKII function in synaptic and behavioral memory. Nat. Rev. Neurosci. 3, 175–190 (2002).

  37. 37.

    Conditioned and unconditional components of post-shock freezing. Pavlov. J. Biol. Sci. 15, 177–182 (1980).

  38. 38.

    Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47–60 (1984).

  39. 39.

    et al. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The selfotel investigators. J. Neurosurg. 91, 737–743 (1999).

  40. 40.

    , , , & Termination of acute stroke studies involving selfotel treatment. ASSIST steering committed. Lancet 349, 32 (1997).

  41. 41.

    et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118, 687–698 (2004).

  42. 42.

    , & Ischemia opens neuronal gap junction hemichannels. Science 312, 924–927 (2006).

  43. 43.

    et al. Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels. Mol. Neurodegener. 2, 11 (2007).

  44. 44.

    & The Rat Brain in Stereotaxic Coordinates (Academic Press, San Diego, 1998).

  45. 45.

    , , , & Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol. Ther. 3, 225–232 (2001).

  46. 46.

    , , , & Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. J. Neurophysiol. 95, 2590–2601 (2006).

  47. 47.

    , & NeuN, a neuronal specific nuclear protein in vertebrates. Development 116, 201–211 (1992).

  48. 48.

    & Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. J. Physiol. (Lond.) 486, 83–95 (1995).

  49. 49.

    et al. α5GABAA receptors mediate the amnestic, but not sedative-hypnotic, effects of the general anesthetic etomidate. J. Neurosci. 26, 3713–3720 (2006).

Download references

Acknowledgements

We thank M. Aarts and W. Czerwinski for technical information, J.C. Roder for advice on MWM testing, and A. Fleig, C. Montell, A. Scharenberg and E. Lo for a critical review of the manuscript. This work was supported by grants from the Canadian Institute of Health Research (MOP68939 and MOP89720 to M.T. and MOP15514 to J.F.M.), the US National Institutes of Health (NS048956 to M.T.), the Canadian Stroke Networks (M.T., J.F.M. and M.F.J.) and the Krembil Seed fund (M.T.). H.-S.S. is a recipient of Postdoctoral Fellowship Awards from the Heart and Stroke Foundation of Canada Focus on Stroke Training Initiative Program.

Author information

Affiliations

  1. Toronto Western Hospital Research Institute, Toronto, Ontario, Canada.

    • Hong-Shuo Sun
    • , Lucy Teves
    • , Hong Cui
    • , Michael Jones
    • , Joan P Forder
    •  & Michael Tymianski
  2. Department of Physiology, University of Toronto, Toronto, Ontario, Canada.

    • Michael F Jackson
    • , Beverley A Orser
    • , John F MacDonald
    •  & Michael Tymianski
  3. Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.

    • Michael F Jackson
    •  & John F MacDonald
  4. Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

    • Loren J Martin
    • , Beverley A Orser
    •  & Michael Tymianski
  5. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

    • Karen Jansen
    •  & Todd E Golde
  6. Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

    • Shigeki Kiyonaka
    •  & Yasuo Mori
  7. Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

    • Beverley A Orser
  8. Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

    • Michael Tymianski

Authors

  1. Search for Hong-Shuo Sun in:

  2. Search for Michael F Jackson in:

  3. Search for Loren J Martin in:

  4. Search for Karen Jansen in:

  5. Search for Lucy Teves in:

  6. Search for Hong Cui in:

  7. Search for Shigeki Kiyonaka in:

  8. Search for Yasuo Mori in:

  9. Search for Michael Jones in:

  10. Search for Joan P Forder in:

  11. Search for Todd E Golde in:

  12. Search for Beverley A Orser in:

  13. Search for John F MacDonald in:

  14. Search for Michael Tymianski in:

Contributions

H.-S.S. carried out the stereotactic rAAV infections, sectioning, immunochemistry, imaging, cell counts, laser dissection microcapture and PCR. K.J. and T.E.G. designed and manufactured the rAAV vectors, M.F.J. and J.F.M. performed the electrophysiology experiments, L.T. carried out the 4VO and histology procedures, Y.M. generated the antibodies to TRPM7, S.K. and H.C. performed the immunoblots, M.J. carried out the TUNEL cell counts, and J.P.F., M.J., H.C. and H.-S.S. performed the OGD experiments. L.J.M. and B.A.O. carried out the neurobehavioral evaluations. M.T. and H.-S.S. wrote the paper. All authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to Michael Tymianski.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–11, Supplementary Table 1 and Supplementary Notes

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nn.2395

Further reading